AstraZeneca - ADR Financials

$161.49

$-3.29 (-1.99%)

As on 04-Sep-2026 13:37EDT

Market cap

$255,541 Mln

Revenue (TTM)

$61,366 Mln

P/E Ratio

24.2

P/B Ratio

Div. Yield

2 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	61,366.00	58,739.00	54,073.00	45,811.00	44,351.00	37,417.00
Cost of Revenue	11,120.00	10,633.00	10,207.00	8,268.00	12,391.00	12,437.00
Gross Profit	50,246.00	48,106.00	43,866.00	37,543.00	31,960.00	24,980.00
Operating Expenses	36,275.00	34,363.00	33,863.00	29,350.00	28,203.00	23,924.00
Operating Profit (EBIT)	13,971.00	13,743.00	10,003.00	8,193.00	3,757.00	1,056.00
Other Income	--	--	--	--	--	--
Profit before Tax	12,586.00	12,402.00	8,691.00	6,899.00	2,501.00	-265.00
Provision for Tax	2,133.00	2,169.00	1,650.00	938.00	-792.00	-380.00
Profit after Tax (Net Income)	10,446.00	10,255.00	7,035.00	5,955.00	3,288.00	112.00
Minority Interest	-7.00	-8.00	-6.00	-6.00	-5.00	-3.00
Consolidated Profit	4,859.00	10,225.00	7,035.00	5,955.00	--	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	50,236.26	48,667.00	40,786.00	39,143.00	37,037.00	39,268.00
Minority Interest	-7.00	--	--	--	--	--
Non-Current Liabilities	33,870.40	34,738.00	35,298.00	31,411.00	33,132.00	43,482.00
Current Liabilities	31,516.15	30,617.00	27,866.00	30,542.00	26,293.00	22,594.00
Total Liabilities	147,213.88	114,074.00	104,035.00	101,119.00	96,483.00	105,363.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	87,765.39	85,351.00	78,208.00	76,065.00	73,890.00	79,119.00
Current Assets	27,932.34	28,723.00	25,827.00	25,054.00	22,593.00	26,244.00
Total Assets	147,218.07	114,074.00	104,035.00	101,119.00	96,483.00	105,363.00
Total Debt*	32,201.35	29,703.00	30,114.00	28,622.00	29,143.00	30,688.00
Net Current Assets	-3,588.00	-1,894.00	-2,039.00	-5,488.00	-3,700.00	3,650.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	14,575.00	11,861.00	10,345.00	9,808.00	5,963.00
Cash Flow from Investing Activities	--	-6,808.00	-7,980.00	-4,064.00	-2,960.00	-11,058.00
Cash from Financing Activities	--	-7,544.00	-3,996.00	-6,567.00	-6,823.00	3,649.00
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	6.69	6.57	4.50	3.81	2.11	0.07
Cash EPS ($)	6.81	10.24	7.75	6.98	5.48	2.72
Adjusted Book Value ($)	32.43	31.16	26.11	25.08	23.76	25.38
Dividend per Share ($)	2.00	--	--	--	--	--
Cash Flow per Share ($)	--	9.33	7.59	6.63	6.29	3.85
Free Cash Flow per Share ($)	--	5.55	4.66	4.21	4.64	2.43

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	13.74	10.15	8.89	4.83	0.21
ROE (%)	21.11	22.93	17.60	15.63	8.62	0.41
ROA (%)	7.13	9.40	6.86	6.03	3.26	0.13
EBIT Margin (%)	23.34	24.00	19.18	18.53	8.64	2.70
Net Margin (%)	17.02	17.46	13.01	13.00	7.41	0.30
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	8.61	0.09	0.18	0.03	0.19	0.41
EBIT Growth (%)	22.42	35.89	22.21	121.56	278.93	-80.51
Net Profit Growth (%)	25.95	45.77	18.14	81.11	2,835.71	-96.50
EPS Growth (%)	25.89	0.46	0.18	0.81	28.13	-0.97
Book Value Growth (%)	12.27	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	24.20	14.00	14.55	17.65	32.15	804.58
Price / Book Value	5.01	2.95	2.51	2.69	2.85	2.29
Dividend Yield (%)	2.00	--	--	--	--	--
EV/EBITDA	13.69	8.45	8.22	9.53	14.16	22.37
Close Price ($)	189.62	91.93	65.52	67.35	67.80	58.25
High Price ($)	212.71	94.02	87.68	76.56	71.70	64.21
Low Price ($)	68.62	61.24	60.47	61.73	52.65	46.48
Market Cap ($ Cr)	255,541.12	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.47	0.61	0.74	0.73	0.79	0.78
Short term debt to equity ratio	0.12	0.07	0.06	0.14	0.15	0.05
Current Ratio	0.89	0.94	0.93	0.82	0.86	1.16
Quick Ratio	0.67	0.72	0.74	0.64	0.68	0.76
Interest Coverage	8.26	8.32	6.17	5.34	2.88	0.79

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	26.02	25.84	20.78	18.35	20.73	21.73
Asset Turnover	0.42	0.54	0.53	0.46	0.44	0.43
Receivable days	--	82.12	66.34	70.16	71.34	67.27
Inventory Days	--	203.44	191.66	223.60	201.65	190.99
Payable days	--	496.71	123.58	128.49	79.20	75.98
Cash Conversion Cycle	--	-211.15	134.42	165.27	193.78	182.29

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)